Sept. 8, 2020 |
H.R.8190 |
To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes. |
1 |
All Democrats |
Sponsor introductory remarks on measure. (CR H4487) |
July 30, 2020 |
H.R.7873 |
To amend the Public Health Service Act to give a preference, with respect to project grants for preventive health services, for States that allow trained individuals to carry and administer epinephrine, and for other purposes. |
1 |
All Democrats |
Referred to the House Committee on Energy and Commerce. |
March 9, 2020 |
H.R.6155 |
To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes. |
0 |
|
Referred to the House Committee on Energy and Commerce. |
Feb. 28, 2019 |
H.R.1447 |
To amend title XIX of the Social Security Act to equalize the Federal medical assistance percentage applicable to certain individuals in the expansion population of the Patient Protection and Affordable Care Act. |
0 |
|
Referred to the Subcommittee on Health. |
Sept. 27, 2018 |
H.RES.1096 |
Expressing the sense of the House of Representatives that the integrity of Medicare should be preserved by maintaining the current eligibility age of 65. |
0 |
|
Referred to the Subcommittee on Health. |
May 21, 2018 |
H.R.5891 |
To establish an interagency task force to improve the Federal response to families impacted by substance abuse disorders. |
18 |
Bipartisan |
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
April 26, 2018 |
H.R.5635 |
To amend title XIX of the Social Security Act to impose restrictions under the Medicaid program with respect to opioid prescriptions, and for other purposes. |
0 |
|
Referred to the House Committee on Energy and Commerce. |